We are monitoring the impact of COVID-19 on Europe Immunoassay Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1491
Share on
Share on

Europe Immunoassay Market Research Report – Segmented By Technology, Application, End Users, Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends and Forecast (2020 to 2025)

Pulished: February, 2020
ID: 1491
Pages: 132

Europe Immunoassay Market Size (2020 to 2025)

The size of the European Immunoassay Market was valued at USD 5.15 Billion in 2020. It is estimated to reach USD 8.22 Billion by the end of 2024, growing at a CAGR of 9.82% between 2020 to 2025.

Europe expected to show reasonable growth due to growing immune assays' applications in diagnosing drug testing for various diseases.

Immunoassay is a biochemical test to measure the presence and concentration of a macromolecule. The macromolecule can be large proteins or antibodies that a person has produced due to an invasion of foreign matter. These assays are more adaptable and can be applied to various formats reliant on the end-user's needs. The principle constitutes an immunoassay designed to detect a specific antigen, such as nucleoprotein, which has been selected precisely to ensure the antigen's identification at low concentration with high specificity not react with similar analytes.

Europe immunoassays market is mainly driven by the rising prevalence of infectious diseases, increasing aging population, advancements in novel assays in various diseases such as Cardiology and oncology, growing applications in diagnosing drug monitoring tests, infectious diseases and identification of cancer biomarkers, increasing need for reagents, sensitive assays and analytical techniques, availability of a wide range of reagents, the introduction of novel biomarkers, growing government and corporate investment in the pharmaceutical and biotechnology segment in emerging markets.

Lack of reimbursement policies, adoption of immunoassays in emerging markets, and stringent regulations for storage hinder the growth of the market.

This research report on the European Immunoassay Market has been segmented & sub-segmented the market into the following categories:

By Technology:

  • Enzyme Immunoassays
  • Fluorescent Immunoassays
  • Chemiluminescence Immunoassays
  • Nephelometric Immunoassays
  • Radio Immunoassays
  • Counting Immunoassays
  • Turbidimetric Immunoassays

By Application:

  • Oncology
  • Cancer
  • Hematology
  • Cardiology
  • Thyroid
  • Infectious diseases
  • Allergies

By End User:

  • Hospitals
  • Clinics
  • Academic Research Institute
  • Pharmaceutical
  • Biotech vendors
  • Laboratories

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Notable companies dominating the European immunoassay market analyzed in this report are Roche Diagnostics, DiaSorin S.p. A, Beckman Coulter, Siemens Healthcare, Ortho Clinical Diagnostics, bioMerieux, Thermo Fisher Scientific and Abbott Laboratories, Akers Biosciences, Inc, Becton Dickinson and Company, Devon Medical Products, EDP Biotech Corporation, Hologic (Gen-Probe), Intrinsic LifeSciences.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Technology                

                                5.1.1 Introduction           

                                5.1.2 Enzyme Immunoassay       

                                5.1.3 Fluorescent Immunoassays             

                                5.1.4 Cheniluminescence Immunoassays              

                                5.1.5 Nephelometric Immunoassays       

                                5.1.6 Radio Immunoassays         

                                5.1.7 Counting Immunoassays  

                                5.1.8 Counting Immunoassays  

                                5.1.9 Others      

                                5.1.10 Y-o-Y Growth Analysis, By Technology      

                                5.1.11 Market Attractiveness Analysis, By Technology     

                                5.1.12 Market Share Analysis, By Technology      

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Oncology 

                                5.2.3 Cancer      

                                5.2.4 Hematology           

                                5.2.5 Cardiology               

                                5.2.6 Thyroid     

                                5.2.7 Infectious disease

                                5.2.8 Allergies   

                                5.2.9 Others      

                                5.2.10 Y-o-Y Growth Analysis, By Application       

                                5.2.11 Market Attractiveness Analysis, By Application     

                                5.2.12 Market Share Analysis, By Application      

                5.3 End users                    

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Clinics        

                                5.3.4 Academic research institutes          

                                5.3.5 Pharmaceutical and Biotech vendors           

                                5.3.6 Laboratories           

                                5.3.7 Others      

                                5.3.8 Y-o-Y Growth Analysis, By End users            

                                5.3.9 Market Attractiveness Analysis, By End users           

                                5.3.10 Market Share Analysis, By End users          

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Technology

                                                6.1.3.3 By Application

                                                6.1.3.4 By End users

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Technology

                                                6.1.4.3 By Application

                                                6.1.4.4 By End users

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Technology

                                                6.1.5.3 By Application

                                                6.1.5.4 By End users

                6.2 U.K                

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Roche Diagnostics                    

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 DiaSorin S.p.A                           

                8.3 Beckman Coulter                     

                8.4 Siemens Healthcare                

                8.5 Ortho Clinical Diagnostics                     

                8.6 bioMerieux                

                8.7 Thermo Fisher Scientific                        

                8.8 Abbott Laboratories               

                8.9 Akers Biosciences                    

                8.10 Becton Dickinson and Company                      

                8.11 Devon Medical Products                    

                8.12 EDP Biotech Corporation                    

                8.13 Hologic                       

                8.14 Intrinsic LifeSciences                           

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  2. Europe Enzyme Immunoassay Market, By Region, From 2020 to 2025 (USD Billion)
  3. Europe Fluorescent Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  4. Europe Cheniluminescence Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  5. Europe Nephelometric Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  6. Europe Radio Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  7. Europe Counting Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  8. Europe Turbidimetric Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  9. Europe Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  10. Europe Oncology Market, By Region, From 2020 to 2025 (USD Billion)
  11. Europe Cancer Market, By Region, From 2020 to 2025 (USD Billion)
  12. Europe Hematology Market, By Region, From 2020 to 2025 (USD Billion)
  13. Europe Cardiology Market, By Region, From 2020 to 2025 (USD Billion)
  14. Europe Thyroid Market, By Region, From 2020 to 2025 (USD Billion)
  15. Europe Infectious diseases Market, By Region, From 2020 to 2025 (USD Billion)
  16. Europe Allergies Market, By Region, From 2020 to 2025 (USD Billion)
  17. Europe Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  18. Europe Hospitals Market, By Region, From 2020 to 2025 (USD Billion)
  19. Europe Clinics Market, By Region, From 2020 to 2025 (USD Billion)
  20. Europe Academic research institutes Market, By Region, From 2020 to 2025 (USD Billion)
  21. Europe Pharmaceutical and biotech vendors Market, By Region, From 2020 to 2025 (USD Billion)
  22. Europe laboratories Market, By Region, From 2020 to 2025 (USD Billion)
  23. U.K. Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  24. U.K. Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  25. U.K. Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  26. Germany Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  27. Germany Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  28. Germany Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  29. France Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  30. France Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  31. France Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  32. Italy Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  33. Italy Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  34. Italy Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  35. Spain Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  36. Spain Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  37. Spain Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample